Viracor-Ibt Laboratories, Inc.
Records under this name other than the patents Viracor-Ibt Laboratories, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 2 patents it holds.
Showing 1 to 4 of 4 · Back to Viracor-Ibt Laboratories, Inc.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 7,476,514 | Method for Monitoring the Immune Response and Predicting Clinical Outcomes in Transplant Recipients Formerly held Term ended Term ended Jun 4, 2024 · High confidence | Term ended | Term ended Jun 4, 2024 | High confidence |
| US 7,169,571 | Methods for Measurement of Lymphocyte Function Term ended Ended no later than Sep 26, 2018 · Low confidence | Term ended | Ended no later than Sep 26, 2018 | Low confidence |
| US 6,630,316 | Method for measurement of lymphocyte function Term ended Ended no later than Mar 26, 2016 · USPTO record | Term ended | Ended no later than Mar 26, 2016 | USPTO record |
| US 5,773,232 | Methods for measurement of lymphocyte function Term ended Term ended no later than Jun 30, 2018 · Low confidence | Term ended | Term ended no later than Jun 30, 2018 | Low confidence |